Peptide Sequence Analysis: 7 Essential Methods for Verifying Amino Acid Order and Structural Identity
Peptide sequence analysis is the analytical examination of the order and identity of amino acid residues within a peptide. It provides structural information that cannot always be obtained from molecular weight measurements, chromatographic purity results or a molecular formula alone.
Two synthetic peptides may contain exactly the same amino acids and have identical molecular masses while differing in the arrangement of those residues. A high-resolution mass spectrometer may establish that both molecules have the expected elemental composition without distinguishing their sequences.
For this reason, confirming a peptide’s molecular mass is not necessarily equivalent to verifying its complete amino acid order.
Laboratories use several complementary techniques to investigate peptide sequences. Tandem mass spectrometry (MS/MS) provides fragmentation patterns that can support residue-order assignments. Edman degradation can identify successive N-terminal residues in suitable peptides, while amino acid composition analysis provides information about the residues present.
Other methods, including enzymatic fragmentation, specialised chromatography, nuclear magnetic resonance (NMR) spectroscopy and stereochemical analysis, may be useful when particular structural questions remain unresolved.
The appropriate analytical strategy depends on the peptide’s length, chemical modifications, molecular architecture and the level of structural certainty required.
This article examines seven methods relevant to peptide sequence analysis, explains how sequence information is interpreted and discusses the limitations of common analytical techniques.
What Is Peptide Sequence Analysis?
Peptide sequence analysis is the process of determining or verifying the arrangement of amino acid residues in a peptide.
Peptides consist of amino acid residues connected primarily through peptide bonds.
For a conventional linear peptide, the sequence is usually written from the N-terminus to the C-terminus.
The N-terminus is the end associated with the amino group, while the C-terminus is associated with the carboxyl group, although terminal modifications may change their chemical forms.
Amino Acid Composition vs Amino Acid Sequence
Composition describes which amino acids are present and their relative amounts.
Sequence describes their order.
Consider two hypothetical tripeptides:
- Ala–Gly–Ser
- Ser–Gly–Ala
Both contain one alanine, one glycine and one serine residue.
Their compositions are identical, but their sequences differ.
They also have identical molecular masses when their terminal groups and other modifications are equivalent.
This distinction explains why peptide sequence analysis requires evidence beyond intact molecular-mass measurement.
Sequence Verification vs Sequence Determination
Sequence verification evaluates whether analytical findings support a proposed amino acid sequence.
Sequence determination attempts to establish the sequence when it is unknown or insufficiently characterised.
These objectives overlap but are not identical.
A known synthetic peptide may be evaluated using a targeted analytical strategy, whereas an unknown peptide may require more extensive structural analysis.
Why Peptide Sequence Analysis Matters
A peptide’s amino acid order influences its molecular structure and physicochemical behaviour.
Even a single residue substitution or sequence rearrangement can change relevant characteristics.
Molecular Identity
Sequence evidence can support identification of the intended peptide.
Synthesis Quality
Analytical methods may reveal certain sequence-related impurities arising during synthesis.
Structural Modifications
Sequence analysis may help identify or localise chemical modifications.
Batch Consistency
Appropriate analytical comparisons can support assessment of material consistency.
Research Reproducibility
Uncertainty about sequence identity can complicate interpretation of laboratory findings.
Quality Documentation
Sequence-related results may contribute to a broader analytical characterisation report.
However, peptide sequence analysis does not independently establish quantitative peptide content, chromatographic purity or every other quality attribute.
7 Essential Methods for Peptide Sequence Analysis
Different techniques provide different types of sequence information.
The seven methods below are not universally required for every synthetic peptide. Laboratories select methods according to the structure and analytical objective.
1. Tandem Mass Spectrometry (MS/MS)
Tandem mass spectrometry is one of the principal techniques used for modern peptide sequence analysis.
It provides structural information by examining the fragmentation of selected peptide ions.
How Tandem Mass Spectrometry Works
A peptide is ionised and a precursor ion is selected.
The selected ion undergoes fragmentation.
The resulting product ions are measured according to their mass-to-charge ratios.
The observed fragment masses can provide information about the peptide’s amino acid sequence.
Sequence-Related Fragment Ions
Peptide fragmentation can produce several ion series.
Two commonly discussed series are:
- b ions, which generally retain the N-terminal portion of the peptide.
- y ions, which generally retain the C-terminal portion.
The mass differences between suitable consecutive fragments may correspond to amino acid residue masses.
Illustrative Fragmentation Example
Consider a hypothetical peptide with the sequence:
Ala–Gly–Ser–Lys
A series of sequence-related fragment ions may provide evidence about successive residues.
If appropriate fragments are observed and assigned correctly, the mass differences can support the proposed residue order.
However, actual spectra may contain missing ions, alternative fragmentation products or interfering signals.
Collision-Induced Fragmentation
Collision-induced dissociation and higher-energy collisional dissociation are widely used fragmentation approaches.
The resulting information depends on the precursor ion, collision conditions and peptide structure.
Why MS/MS Is Useful
MS/MS can support sequence verification and investigation of certain chemical modifications.
Limitations of MS/MS
Not every peptide produces complete fragment coverage.
Some amino acids are difficult to distinguish using conventional mass-based fragmentation.
Leucine and isoleucine, for example, have identical residue masses.
A routine MS/MS spectrum may therefore be unable to distinguish these residues at a particular position.
Reliable peptide sequence analysis should report the sequence information actually supported by the observed fragments.
2. High-Resolution Mass Spectrometry
High-resolution mass spectrometry provides accurate mass measurements that can support peptide sequence assignments.
Although accurate intact mass does not establish residue order, it can constrain the possible molecular compositions.
Exact Mass Measurement
High-resolution instruments can measure mass-to-charge ratios with high precision under suitable conditions.
Molecular Formula Assessment
Accurate mass and isotope information may support an elemental-composition assignment.
Fragment Mass Accuracy
High-resolution MS/MS can improve the interpretation of sequence-related product ions.
Chemical Modification Detection
Certain modifications produce characteristic mass differences.
For example, addition of one oxygen atom produces a monoisotopic mass increase of approximately 15.9949 Da.
Why High Resolution Helps
Accurate fragment masses can help distinguish possible assignments that would be ambiguous at lower mass resolution.
Limitations
Even highly accurate mass measurements cannot always distinguish isomeric structures.
Peptide sequence analysis benefits from high-resolution mass spectrometry when its results are combined with appropriate fragmentation and structural interpretation.
Read Peptide Molecular Weight.
3. Edman Degradation
Edman degradation is a classical chemical sequencing technique used to identify successive amino acid residues from the N-terminus of suitable peptides or proteins.
Basic Principle
The method involves chemical modification and cleavage of the N-terminal residue.
The released derivative can then be identified.
The process may be repeated to examine successive residues.
Why Edman Degradation Is Useful
It can provide direct information about amino acid order from an accessible N-terminus.
Sequence Direction
Edman sequencing proceeds from the N-terminal end.
Limitations
The method requires a suitable accessible N-terminus.
Certain N-terminal modifications can interfere with conventional Edman degradation.
The practical sequence length is also limited by cumulative losses and analytical performance.
Complementary Role
Edman degradation may be useful when mass-spectrometric results are ambiguous or when an independent sequence-related method is required.
However, it is not necessary for every routine peptide identity assessment.
Peptide sequence analysis should use Edman degradation only when the molecular structure and analytical objective make it appropriate.
4. Amino Acid Composition Analysis
Amino acid analysis determines the identities and quantities of amino acid constituents under the conditions of the analytical method.
How It Works
A peptide may be hydrolysed into its constituent amino acids.
The resulting components are then separated and measured using an appropriate analytical technique.
What It Can Confirm
Amino acid analysis can provide evidence about the expected residue composition.
Example
A hypothetical peptide is expected to contain:
- Two glycine residues.
- One alanine residue.
- One lysine residue.
A suitable composition analysis may support this expected composition.
What It Cannot Confirm
Composition analysis does not establish the order of the residues.
Two different sequences may contain identical numbers of each amino acid.
Analytical Limitations
Some residues may undergo chemical changes during hydrolysis.
Other residues may require specialised analytical conditions.
Role in Sequence Verification
Amino acid analysis is most useful as complementary evidence.
Peptide sequence analysis should not treat composition agreement as complete sequence confirmation.
5. Enzymatic Fragmentation and Peptide Mapping
Peptide mapping examines fragments generated from a larger peptide or protein.
For suitable substrates, enzymatic cleavage can produce fragments that provide information about sequence organisation.
Cleavage Specificity
Certain enzymes preferentially cleave peptide bonds associated with particular residues or sequence contexts.
Fragment Identification
The resulting fragments may be analysed by chromatography and mass spectrometry.
Sequence Coverage
Overlapping or complementary fragments can support sequence assignments.
Why Mapping Helps
Fragment mapping can reduce the complexity of some structural questions.
Limitations
Not every synthetic peptide contains suitable cleavage sites.
Short peptides may provide limited opportunities for informative enzymatic fragmentation.
Incomplete cleavage, unexpected cleavage or chemical modifications may complicate interpretation.
Alternative Fragmentation Strategies
Chemical cleavage or other approaches may be considered where suitable.
Peptide sequence analysis using mapping techniques should be designed around the actual peptide sequence and structure.
6. Nuclear Magnetic Resonance Spectroscopy
NMR spectroscopy can provide information about molecular structure and chemical environments.
It may contribute to peptide sequence analysis when sufficient spectral information can be obtained.
Chemical Environment
NMR signals reflect the local chemical environments of atomic nuclei.
Structural Connectivity
Suitable multidimensional experiments can provide information about relationships between atoms and residues.
Sequence-Related Assignments
In favourable cases, NMR data can support residue assignments and structural connectivity.
Conformational Information
NMR may also provide information about peptide conformation.
Limitations
Spectral complexity can increase with peptide size.
Sample quantity, concentration and solvent conditions can affect feasibility.
NMR is not necessarily the most efficient method for routine sequence verification.
Complementary Evidence
For selected structural questions, NMR can provide information that is not available from intact mass alone.
Peptide sequence analysis may use NMR when additional structural characterisation is scientifically justified.
7. Specialised Stereochemical and Structural Analysis
Some peptide structures contain features that cannot be fully characterised through routine mass spectrometry.
These may include D-amino acids, cyclic structures, disulfide bonds or unusual chemical modifications.
D- and L-Amino Acids
Many amino acids exist in different stereochemical configurations.
D- and L-forms have the same elemental composition and molecular mass.
Chiral Analysis
Suitable chiral methods may help investigate amino acid stereochemistry.
Disulfide Connectivity
Peptides containing multiple cysteine residues may form different disulfide arrangements.
These arrangements can share the same overall molecular mass.
Cyclic Peptides
Cyclic structures may require specialised fragmentation or other structural approaches.
Non-Standard Residues
Some synthetic peptides contain chemically modified or non-proteinogenic amino acids.
Why Specialised Testing Matters
A peptide may have the expected amino acid composition and intact molecular mass while differing in stereochemistry or connectivity.
Peptide sequence analysis must account for these characteristics when they form part of the intended structure.
Comparison of the Seven Peptide Sequence Analysis Methods
| Method | Main information | Important limitation |
|---|---|---|
| MS/MS | Sequence-related fragmentation evidence | Incomplete coverage and isomeric ambiguities |
| High-resolution MS | Accurate intact and fragment masses | Mass alone does not establish sequence order |
| Edman degradation | Successive N-terminal residue information | Requires a suitable accessible N-terminus |
| Amino acid analysis | Residue composition | Does not establish residue order |
| Peptide mapping | Fragment identities and sequence coverage | Depends on suitable cleavage and mapping |
| NMR | Selected structural and connectivity information | Complex interpretation and sample requirements |
| Specialised structural analysis | Stereochemistry, disulfide connectivity and unusual structures | Method requirements vary by peptide |
A robust peptide sequence analysis strategy uses complementary evidence rather than assuming that one method answers every structural question.
Understanding b-Ion and y-Ion Series in MS/MS
Fragment ion series are central to many mass-spectrometric sequence assignments.
b-Ion Series
A b-ion series generally contains fragments retaining the N-terminal portion of a peptide.
y-Ion Series
A y-ion series generally contains fragments retaining the C-terminal portion.
Residue Mass Differences
The mass difference between suitable consecutive fragments may correspond to an amino acid residue.
Sequence Interpretation
A series of informative fragments can support the order of residues.
Missing Fragments
Not every theoretically possible fragment will necessarily be observed.
Alternative Fragmentation
Internal fragments, neutral losses and other product ions may appear.
Ambiguous Assignments
Some fragment masses can correspond to more than one possible explanation.
Accurate peptide sequence analysis requires consideration of the complete spectrum, mass accuracy and plausible fragmentation pathways.
Can Two Different Peptide Sequences Have the Same Molecular Weight?
Yes.
Different amino acid arrangements can have identical molecular masses.
Same Residues, Different Order
Consider:
Ala–Gly–Ser
and
Ser–Gly–Ala
The two peptides contain the same amino acids and have identical elemental compositions.
Leucine and Isoleucine
Leucine and isoleucine are structural isomers with the same residue mass.
D- and L-Residues
Stereochemical differences do not necessarily change molecular mass.
Positional Modifications
A modification at different positions may produce the same total mass change.
Why Sequence Evidence Is Needed
Intact mass can support a molecular composition but does not uniquely identify every structure.
This is why peptide sequence analysis often requires MS/MS or other complementary methods.
Read Peptide Identity Testing.
Peptide Sequence Analysis vs Peptide Identity Testing
These concepts overlap but are not identical.
Peptide sequence analysis focuses on the amino acid order and related structural features.
Peptide identity testing addresses whether the material is consistent with the intended chemical substance.
Identity testing may include sequence-related methods, intact mass measurements and chromatographic comparisons.
Sequence Analysis
Examines amino acid order and potentially modifications or connectivity.
Identity Testing
Evaluates evidence supporting the proposed molecular identity.
Why Both Matter
A correct molecular mass does not establish complete sequence identity.
A sequence assignment also does not independently establish chromatographic purity or quantitative content.
Peptide Sequence Analysis vs HPLC Purity Testing
HPLC purity testing and sequence analysis answer different questions.
| Characteristic | Sequence analysis | HPLC purity testing |
|---|---|---|
| Main question | What amino acid order is supported? | What components are separated and detected? |
| Common methods | MS/MS, Edman degradation, mapping | HPLC |
| Main result | Sequence-related structural evidence | Relative chromatographic composition |
| Key limitation | May not resolve all structural ambiguities | Does not independently establish sequence identity |
A sample could exhibit a principal HPLC peak representing 99% of the integrated detector response while containing an incorrectly synthesised peptide.
The chromatogram alone would not establish the complete amino acid sequence.
Read HPLC Peptide Purity Testing.
How Sequence Errors Can Arise During Peptide Synthesis
Synthetic peptide production involves repeated chemical reactions.
Different types of sequence-related impurities may arise.
Deletion Sequences
A residue may be absent because of incomplete coupling or other synthesis-related events.
Truncated Sequences
A peptide chain may terminate before the intended sequence is complete.
Insertion-Related Variants
Additional residues may be incorporated under certain manufacturing error scenarios.
Sequence Rearrangements
Unexpected structural changes may occur in particular chemical systems.
Side-Reaction Products
Chemical reactions involving susceptible residues can generate modified species.
Stereochemical Changes
Certain synthetic conditions may contribute to racemisation or epimerisation.
Analytical Detection
Some variants produce measurable mass differences.
Others may require more specialised techniques.
Peptide sequence analysis can help characterise selected synthesis-related variants, but complete impurity assessment may require additional analytical methods.
Read Peptide Impurity Profiling.
How Chemical Modifications Affect Sequence Analysis
Chemical modifications can influence the interpretation of peptide fragmentation and molecular mass.
Oxidation
Oxidation of certain residues may produce characteristic mass shifts.
Deamidation
Deamidation can change the chemical structure and mass of susceptible residues.
Terminal Modifications
N-terminal and C-terminal modifications must be included in the proposed molecular structure.
Disulfide Bonds
Disulfide connectivity can influence fragmentation behaviour.
Isomerisation
Some structural rearrangements occur without a change in elemental composition.
Modification Localisation
MS/MS may help determine which sequence region contains a modification.
Limitations
A mass shift may support a modification assignment without uniquely establishing its position.
Peptide sequence analysis should distinguish between detection of a modification and definitive localisation.
Read Peptide Oxidation and Degradation.
Peptide Sequence Analysis in Batch Testing
Sequence-related testing can contribute to broader batch quality control.
Material Identification
The tested material should be associated with an identifiable sample or batch.
Sequence Verification
Suitable methods may support the proposed amino acid order.
Molecular-Mass Assessment
Intact mass provides complementary identity evidence.
Impurity Profiling
Related sequences and chemical modifications may be investigated.
Chromatographic Purity
HPLC or other methods can assess detectable components.
Quantitative Content
A separate quantitative method may be needed to establish peptide content.
Documentation
The analytical findings should be recorded and traceable.
Peptide sequence analysis is one part of peptide quality characterisation, not a replacement for all other testing.
Read Peptide Batch Testing.
Example of a Hypothetical Peptide Sequence Verification Report
Consider a fictional synthetic peptide labelled SEQ-EXAMPLE-001.
The proposed sequence is:
Ala–Gly–Ser–Lys
A laboratory performs several analytical tests.
| Test | Illustrative finding | Interpretation |
|---|---|---|
| Intact LC-MS | Mass consistent with expected structure | Supports molecular-mass identity |
| High-resolution MS/MS | Several sequence-related fragments observed | Supports portions of the proposed residue order |
| Amino acid analysis | Composition consistent with expectation | Supports residue composition |
| HPLC reference comparison | Retention behaviour consistent with reference | Additional identity-related evidence |
| Batch identification | SEQ-EXAMPLE-001 | Links the findings to the fictional sample |
These results are hypothetical and do not represent a commercial product or verified laboratory report.
The example demonstrates why different methods provide complementary information.
Intact mass supports molecular composition.
MS/MS supports sequence-related assignments.
Amino acid analysis supports composition.
Chromatographic comparison adds another analytical characteristic.
The strength of the final sequence assignment depends on the completeness and quality of the evidence.
What Does Sequence Coverage Mean?
Sequence coverage describes the extent to which a proposed sequence is supported by observed analytical evidence.
The term may be defined differently depending on the method and reporting convention.
Fragment Coverage
In MS/MS, fragment ions may support particular sequence positions or bonds.
Missing Regions
Some parts of a peptide may not produce informative fragments.
Ambiguous Residues
Certain residue identities may remain unresolved.
Complementary Fragmentation
Additional fragmentation approaches may improve the available information.
Reporting Limitations
A report should not claim complete sequence verification solely because a subset of expected fragments was observed.
Accurate peptide sequence analysis requires clear reporting of which structural features are established and which remain uncertain.
Why Sequence Verification Can Be Difficult for Modified Peptides
Modified peptides may present additional analytical challenges.
Terminal Blocking Groups
Some modifications can interfere with classical sequencing methods.
Unusual Residues
Non-standard amino acids may require specialised mass calculations or reference information.
Cyclic Structures
Cyclic peptides may fragment differently from linear peptides.
Disulfide Bonds
Disulfide connectivity can complicate structural interpretation.
Stereochemistry
Routine mass-based methods may not distinguish D- and L-configurations.
Multiple Modifications
Several modifications can produce complex spectra.
Method Selection
The analytical strategy should reflect the actual chemical structure.
Peptide sequence analysis is most reliable when methods are selected according to the specific structural questions.
Peptide Sequence Analysis and Certificates of Analysis
A certificate of analysis may report peptide identity, purity or other selected results.
However, not every COA contains complete sequence verification evidence.
Molecular-Mass Results
An LC-MS result may support the expected molecular mass.
Sequence-Related Results
MS/MS or another suitable method may provide sequence evidence.
Chromatographic Purity
HPLC may report relative chromatographic composition.
Batch Number
The certificate should correspond to the material being represented.
Method Identification
The report should specify the relevant analytical methods.
Supporting Data
Spectra or other records may provide additional evidence.
Interpretation
A statement such as “mass confirmed” should not automatically be interpreted as complete sequence verification.
Peptide sequence analysis claims should reflect the methods and evidence actually available.
Read Peptide Certificate of Analysis.
Common Mistakes in Peptide Sequence Analysis
Assuming Molecular Weight Confirms Sequence
Different sequences can share the same molecular mass.
Assuming HPLC Purity Confirms Amino Acid Order
Chromatographic purity does not independently establish sequence identity.
Treating Amino Acid Composition as Sequence
Composition does not determine residue order.
Assuming MS/MS Always Provides Complete Coverage
Fragmentation data may be incomplete.
Ignoring Leucine and Isoleucine Ambiguity
These residues have identical masses.
Overlooking D- and L-Amino Acids
Stereochemical differences may require specialised analysis.
Ignoring Terminal Modifications
Terminal groups can affect analytical interpretation.
Overstating COA Findings
A certificate should only be interpreted as supporting the characteristics actually measured.
Avoiding these mistakes improves the scientific interpretation of peptide sequence analysis.
Analytical Method Validation for Sequence Verification
Methods used for sequence-related testing should be suitable for their intended purpose.
Specificity
The method should provide appropriate discrimination between relevant structures.
Mass Accuracy
Mass measurements should meet suitable performance criteria.
Fragment Interpretation
Sequence assignments should be supported by credible fragment evidence.
Reproducibility
Results should be appropriately consistent under defined conditions.
Reference Materials
Suitable reference materials may support method interpretation.
Data Quality
Spectral and chromatographic quality should be sufficient for the analytical objective.
Documentation
Methods and findings should be recorded.
Limitations
A method should not be described as validated unless the relevant validation work has been completed.
Reliable peptide sequence analysis depends on analytical suitability and transparent reporting.
Scientific Guidance Relevant to Peptide Sequence Analysis
Several established scientific resources provide useful principles for analytical method development and structural characterisation.
ICH Q2(R2)
ICH Q2(R2) addresses validation of analytical procedures.
Its principles may be relevant when evaluating analytical performance within its applicable scope.
ICH Q14
ICH Q14 addresses analytical procedure development.
Mass Spectrometry Literature
Peer-reviewed research provides established principles for peptide ionisation, fragmentation and sequence interpretation.
Pharmacopoeial Resources
Pharmacopoeial standards may provide additional analytical context.
These resources do not automatically establish regulatory compliance for any particular commercial research peptide.
Frequently Asked Questions About Peptide Sequence Analysis
1. What is peptide sequence analysis?
Peptide sequence analysis is the analytical examination of amino acid order and related structural characteristics within a peptide.
2. Can LC-MS confirm a complete peptide sequence?
Intact LC-MS provides molecular-mass evidence. Complete sequence verification may require MS/MS or other complementary techniques.
3. What is the difference between amino acid composition and sequence?
Composition identifies which amino acids are present, while sequence identifies their order.
4. How does MS/MS help determine peptide sequence?
MS/MS produces fragment ions whose masses can support assignments of amino acid residues and their order.
5. Can two peptides have identical molecular weights but different sequences?
Yes. Different residue arrangements and certain structural isomers can share identical molecular masses.
6. What is Edman degradation?
Edman degradation is a chemical sequencing method that identifies successive N-terminal amino acid residues in suitable peptides.
7. Does HPLC purity testing confirm peptide sequence?
No. HPLC purity testing evaluates chromatographic composition and does not independently establish complete amino acid order.
8. Why is peptide sequence analysis important for research materials?
It provides evidence supporting molecular identity and can help identify certain sequence-related variants that may affect laboratory interpretation.
Conclusion: Understanding Peptide Sequence Analysis
Peptide sequence analysis provides structural information about the arrangement of amino acid residues within synthetic peptides.
Tandem mass spectrometry is particularly useful because sequence-related fragment ions can support residue-order assignments.
High-resolution mass spectrometry, Edman degradation, amino acid composition analysis, peptide mapping, NMR and specialised structural methods provide complementary evidence.
However, each technique has limitations.
A correct molecular mass does not establish every amino acid position, and a high HPLC area percentage does not independently confirm sequence identity.
Some structural features, including stereochemistry and particular isomeric arrangements, may require specialised analytical approaches.
Reliable peptide sequence analysis therefore depends on suitable methods, complete structural specifications, traceable samples and careful interpretation of the available evidence.
For laboratory researchers, distinguishing sequence verification from molecular-mass confirmation, chromatographic purity and quantitative peptide content is essential to understanding what an analytical report actually establishes.
Scientific References and Further Reading
- Steen, H., Mann, M. (2004). The ABC’s (and XYZ’s) of Peptide Sequencing. Nature Reviews Molecular Cell Biology, 5, 699–711.
https://doi.org/10.1038/nrm1468 - Aebersold, R., Mann, M. (2003). Mass Spectrometry-Based Proteomics. Nature, 422, 198–207.
https://doi.org/10.1038/nature01511 - Fenn, J. B., Mann, M., Meng, C. K., Wong, S. F., Whitehouse, C. M. (1989). Electrospray Ionization for Mass Spectrometry of Large Biomolecules. Science, 246, 64–71.
https://doi.org/10.1126/science.2675315 - International Council for Harmonisation (ICH). Q2(R2): Validation of Analytical Procedures.
https://www.ich.org/page/quality-guidelines - International Council for Harmonisation (ICH). Q14: Analytical Procedure Development.
https://www.ich.org/page/quality-guidelines - United States Pharmacopeia (USP). Analytical standards and quality resources.
https://www.usp.org/
Research information notice: This article is intended for laboratory education and analytical research. It does not represent verified sequence testing of any Axion Peptide Lab commercial batch, establish regulatory compliance or demonstrate suitability for human or veterinary administration.
4 Responses